Home › What Pharma/Biotech Investors Need To Know About Adaptive Trials
 

Keywords :   


What Pharma/Biotech Investors Need To Know About Adaptive Trials

2016-01-16 19:10:13| Biotech - Topix.net

The FDA allows for adaptive drug trials during which key protocols may be altered during the course of the trial depending on interim results. Investors concerned with pharmaceutical or biotech drug development, from early to late stages, need to be aware of the benefits and risks of adaptive trials because their use and interpretation can impact corporate valuations.

Tags: investors trials adaptive pharmabiotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Fox and The Trade Desk extend ad integrations across Fox's portfolio
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
More »